Processing math: 100%

Notable Life Science mergers & acquisitions in Q4 2016

corresponding

Elisabet Cruces
Companies & Markets Content Manager
Clarivate Analytics
Barcelona, Spain

Powered by

clarivate

The mergers and acquisitions (M&A) activity in the Life Sciences sector in the fourth quarter of 2016 continued with similar tendency as the previous three quarters. In the last months of the year, 107 active M&A deals were reported by Clarivate Analytics Recap with a total disclosed value of 19.9billion.Thevolumewasapproximately1745.6 billion (including the 14.5billionMedivationofferbyPfizerandseveraltransactionswithdisclosedvalueshigherthan3 billion).

DEAL ACTIVITY IN THE 4TH QUARTER FROM 2008 TO 2016
Looking into the same periods over the last eight years, the fourth quarter of 2016 did not reach the values of 2015, which included the 160billionPfizerandAllerganbidterminatedinApril,or2014withthecompleted66 billion Actavis and Allergan merger (Figure 1). However, ...